Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
33%

OVERLAP
BY WEIGHT
13

# OF OVERLAPPING
HOLDINGS
CANC
50
HOLDINGS
26%
ALSO IN HRTS
HRTS
43
HOLDINGS
30%
ALSO IN CANC
SECTOR DRIFT (CANC minus HRTS)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in HRTS
Overlap
ASTRAZENECA PLC 4.4% 4.5% 4.4%
ROCHE HOLDINGS LTD-SPONS ADR 4.9% 4.2% 4.2%
ELI LILLY & CO 3.8% 7.8% 3.8%
NOVARTIS AG 4.6% 3.3% 3.3%
BRIDGEBIO PHARMA, INC. 5.1% 2.9% 2.9%
CANC Overweight Relative to HRTS
REVOLUTION MEDICINES, INC. 4.5%
MERUS N.V. 4.4%
GENMAB A/S SPONSORED ADR 4.1%
BEIGENE LTD. SPONSORED ADR 3.1%
NUVALENT, INC. CLASS A 3.1%
ARCELLX, INC. 3.1%
SUMMIT THERAPEUTICS INC 3.1%
EXELIXIS INC 3.1%
ZAI LAB LTD. UNSPONSORED ADR 2.9%
LEGEND BIOTECH CORPORATION SPONSORED 2.6%
CANC Underweight Relative to HRTS
ABBOTT LABORATORIES -4.7%
UNITEDHEALTH GROUP INC -4.6%
ELI LILLY & CO -3.9%
BOSTON SCIENTIFIC CORP -3.9%
NOVO NORDISK A/S-B -3.5%
THERMO FISHER SCIENTIFIC INC -3.4%
MEDTRONIC PLC -3.0%
CRINETICS PHARMACEUTICALS INC -2.6%
VERTEX PHARMACEUTICALS INC -2.6%
ALNYLAM PHARMACEUTICALS INC -2.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY